About UChicago Medicine at Ingalls - Tinley Park
"UChicago Medicine at Ingalls - Tinley Park offers quick and convenient specialty and primary care for the whole family. Our teams care for children, teens, adults and senior citizens who need annual exams, immunizations, treatment for injuries or help managing chronic illnesses. We also offer on-site urgent care, laboratory testing, X-rays, stress tests and rehabilitation services."
Clinical Trials at UChicago Medicine at Ingalls - Tinley Park
During the past decade, UChicago Medicine at Ingalls - Tinley Park conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UChicago Medicine at Ingalls - Tinley Park"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at UChicago Medicine at Ingalls - Tinley Park
According to Clinical.Site data, the most researched conditions in "UChicago Medicine at Ingalls - Tinley Park" are
"Multiple Myeloma" (2 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "UChicago Medicine at Ingalls - Tinley Park" in a lesser frequency.
Clinical Trials Intervention Types at UChicago Medicine at Ingalls - Tinley Park
Most popular intervention types in "UChicago Medicine at Ingalls - Tinley Park" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "5-FU" (1 trials), "Bevacizumab" (1 trials), "Capecitabine" (1 trials), "Cetuximab" (1 trials) and "Elranatamab + Nirogacestat" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UChicago Medicine at Ingalls - Tinley Park
The vast majority of trials in "UChicago Medicine at Ingalls - Tinley Park" are
3 trials for "All" genders.
Clinical Trials Status at UChicago Medicine at Ingalls - Tinley Park
Currently, there are NaN active trials in "UChicago Medicine at Ingalls - Tinley Park".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in UChicago Medicine at Ingalls - Tinley Park,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UChicago Medicine at Ingalls - Tinley Park, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".